Västra Hamnen Corp. Finance
Bioextrax: High interest and steady progress
- High interest amid progression of the projects
- The rights issue in Q4 added MSEK 14.1
- We keep our fair value of SEK 7.60 per share
Bioextrax has received numerous inquiries from research institutes and companies since the summer. At the same time, the company reports steady progress from its leading projects. In Q4, Bioextrax raised MSEK 14.1 to prolong its financial runway until 2026.
Read the full report here.
Datum | 2024-12-06, kl 11:18 |
Källa | MFN |

CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.